Testing a 6-in-1 infant vaccine in healthy babies
Part of Brain & nervous system, Digestive system, Infections, Lungs & breathing clinical trials.
This study tests a new vaccine that protects babies against 6 diseases (diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib) in just one shot. It’s for healthy infants starting at 6–8 weeks old as their first series of vaccinations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is 6 to 8 weeks old at the time of the first dose.
- Your baby weighs at least 3.2 kg (about 7 pounds).
- Your baby was born full-term (at least 37 weeks of pregnancy).
- Your baby has not already received any of the vaccines in this combination (diphtheria, tetanus, whooping cough, polio, hepatitis B, or Hib).
- Your baby does not have a fever (100.4°F or higher) now or in the last 3 days.
- You (parent or legal guardian) are willing to sign a consent form allowing your baby to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new vaccine (LR20062) to see how well it protects healthy babies against several diseases. Your baby would receive the vaccine at their 2-month, 4-month, and 6-month checkups.
This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.
This study tests an experimental vaccine (BK1803) to see if it is safe and effective in healthy infants aged 2 to 6 months. It may help protect against several serious diseases.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
This trial tests a polio vaccine (sIPV) in healthy people aged 7-50 years. It aims to see how safe and effective the vaccine is, and may help protect against polio.
Hear when a new Diphtheria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.